Response to ranibizumab therapy in neovascular AMD - an evaluation of good and bad responders.

Menghini, M

Response to ranibizumab therapy in neovascular AMD - an evaluation of good and bad responders. [electronic resource] - Klinische Monatsblatter fur Augenheilkunde Apr 2010 - 244-8 p. digital

Publication Type: Journal Article

1439-3999

10.1055/s-0029-1245203 doi


Aged
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Humanized
Dose-Response Relationship, Drug
Female
Humans
Macular Degeneration--drug therapy
Male
Prevalence
Prognosis
Ranibizumab
Retrospective Studies
Risk Assessment
Risk Factors
Sex Distribution
Switzerland--epidemiology
Treatment Outcome